ArticleJournal of the advanced practitioner in oncology2022

Tebentafusp-tebn: A Novel Bispecific T-Cell Engager for Metastatic Uveal Melanoma.

Gwen Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.